Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Goldenseal (Hydrastis canadensis) is a perennial herb native to North America and widely used in traditional medicine. Its primary active compound is berberine[1][3], which exhibits antimicrobial activity against bacteria and fungi in vitro. Goldenseal has been traditionally used for digestive disorders, skin and eye conditions[2], wounds[7], infections of various types[5], and as an insect repellent and diuretic. It may also have effects on cardiovascular health and cancer risk according to some sources[7]. Mechanistically, berberine from goldenseal inhibits cytochrome P450 enzymes CYP3A4 and CYP2D6 in the liver[5], potentially affecting the metabolism of many pharmaceutical drugs. Goldenseal is primarily available as a dietary supplement in forms such as dried root/rhizome powder or liquid extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on goldenseal.